Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin to Prevent Muscle Loss and Insulin Resistance During Bed Rest
NCT03107884Phase 1Active, not recruiting
- Sponsor
- University of Utah
- Start
- Aug 2019
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of liquid metformin (Aspargo Labs) in muscle atrophy and insulin resistance (IR), sponsored by University of Utah. Started Aug 2019; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
muscle atrophyinsulin resistance (IR)
Beyond the preview
Go deeper on NCT03107884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03107884.